文献速递结核与非结核分枝杆菌艾滋病与性传播感染

异烟肼和利福平浓度低的结核-人类免疫缺陷病毒共感染患者痰培养转阴延迟

Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.
PubMed 文献 · Clin Infect Dis · 2018-01-01

研究纳入268例乌干达HIV合并肺结核患者,在治疗第2、8、24周检测异烟肼和利福平浓度并随访痰培养。异烟肼和利福平浓度低者痰培养转阴更慢(HR 0.54,95%CI 0.37-0.77,P=0.001),但治疗失败比例仅4.4%。

要点

  • 异烟肼和利福平浓度低与痰培养转阴延迟相关(HR 0.54,95%CI 0.37-0.77,P=0.001)。
  • 利福平和异烟肼浓度低于阈值及体重<55 kg均为不良治疗结局的危险因素。
  • 仅4.4%的参与者治疗失败,低药物浓度未转化为高治疗失败比例。

核心结论

  • 尽管低抗结核药物浓度未导致高比例治疗失败,但利福平和异烟肼低浓度与培养转阴延迟的关联可能对结核传播有影响。

研究设计与样本

  • 研究纳入268例HIV感染的乌干达肺结核患者,在治疗第2、8、24周给药后1、2、4小时检测一线抗结核药物浓度,每次随访进行系列痰培养,采用时间-事件分析确定与痰培养转阴相关的因素。

主要发现

  • 异烟肼和利福平浓度低的患者在结核治疗结束前痰培养转阴的可能性更低(HR 0.54,95%CI 0.37-0.77,P=0.001)。
  • 异烟肼和利福平浓度低的患者在随访结束时痰培养转阴的可能性更低(HR 0.61,95%CI 0.44-0.85,P=0.003)。
  • 利福平和异烟肼浓度-时间曲线下面积最高四分位组患者发生痰培养转阴的可能性是最低四分位组的两倍。
  • 利福平和异烟肼浓度低于阈值以及体重<55 kg均为不良结核治疗结局的危险因素。
  • 仅4.4%的参与者治疗失败。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The relationship between concentrations of antituberculosis drugs, sputum culture conversion, and treatment outcome remains unclear. We sought to determine the association between antituberculosis drug concentrations and sputum conversion among patients coinfected with tuberculosis and human immunodeficiency virus (HIV) and receiving first-line antituberculosis drugs. METHODS: We enrolled HIV-infected Ugandans with pulmonary tuberculosis. Estimation of first-line antituberculosis drug concentrations was performed 1, 2, and 4 hours after drug intake at 2, 8, and 24 weeks of tuberculosis treatment. Serial sputum cultures were performed at each visit. Time-to-event analysis was used to determine factors associated with sputum culture conversion. RESULTS: We enrolled 268 HIV-infected patients. Patients with low isoniazid and rifampicin concentrations were less likely to have sputum culture conversion before the end of tuberculosis treatment (hazard ratio, 0.54; 95% confidence interval, .37-.77; P = .001) or by the end of follow-up (0.61; .44-.85; P = .003). Patients in the highest quartile for area under the rifampicin and isoniazid concentration-time curves for were twice as likely to experience sputum conversion than those in the lowest quartile. Rifampicin and isoniazid concentrations below the thresholds and weight <55 kg were both risk factors for unfavorable tuberculosis treatment outcomes. Only 4.4% of the participants had treatment failure. CONCLUSION: Although low antituberculosis drug concentrations did not translate to a high proportion of patients with treatment failure, the association between low concentrations of rifampicin and isoniazid and delayed culture conversion may have implications for tuberculosis transmission. Clinical Trials Registration: NCT01782950.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Sekaggya-Wiltshire C, von Braun A, Lamorde M, et al. Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations. Clin Infect Dis. 2018. PMID: 29514175. doi:10.1093/cid/ciy179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。